important-- turning her2+ Stage IV into chronic treatable disease

[Rolepaul]

That is very exciting. I would also like to hear if PDL1 or similar type of drugs are being paired with Herceptin to get better activity. Right now, Perjeta plus TDM-1 is over US$23,000 per treatment. I hope that insurance companies do not decide it is better to have treatment declined and pay a fine versus getting good treatments in place. And I hope we in the pharma/Biotech manufacturing community can get people in place to cut the cost of these drugs.